APHCON BYLAWS |
Statutes and Bylaws: Asia Pacific Hematology Consortium (APHCON)
_______________________________________________
Article 1
Name
The name of this organization is the Asia Pacific Hematology Consortium. The Consortium is a scientific association.
Article II
Objectives
The objectives of the Consortium shall be:
(a) to promote scientific research and medical science in the field of hematology
(b) to nurture educational discourse and cultivate the dissemination of knowledge and ideas relating to hematology-oncology
(c) to promote the continuing education in the investigation of hematology-oncology and related topics by encouraging international discussion and developing a cohesive standardization of hematological methods and standards of care
(d) to advance developments in hematology-oncology by developing and implementing clinical research programs.
As part of its functions, the Consortium will organize, at pre-determined intervals, scientific meetings to be held at least annually and will be called “Bridging the Gap Series: International Conference on Hematologic Malignancies.” The Board of Directors will determine the locations of the scientific meetings. Additionally, the Consortium will publish a scientific journal in concert with a publishing partner.
Article III
Duration
The Consortium is formed for an indefinite period and may be dissolved at any time with unanimous approval by the Board of Directors. The financial year of the Consortium coincides with the calendar year.
Article IV
Membership
1. Definition of Members: The membership of the Consortium consists of the following:
(a) Active Members (Members)
(b) Honorary Members
(c) Emeritus Members
(d) Institutional Members
(e) Corporate Members
a) Active Members
Active members are medical professionals or scientists of good professional standing and demonstrate continuing commitment to the field of hematology. The Membership Committee determines membership eligibility. Interested parties must submit an application to the Consortium. Applicants are informed of their admission via writing.
Application for Membership shall be made on the form authorized by the Consortium, signed by the applicant, recommended by two APHCON and approved by the Membership Committee. The application should include a list of qualifications, professional positions, and scientific contributions of the candidate. Applications are reviewed by the Membership Committee at its next regular meeting.
Active Members are required to pay an annual membership fee, which is set by the APHCON Board. Members under the age of 40 or members who have Emeritus classification receive preferential rates of membership. Members who have paid their membership fee for the current calendar year receive a discount on the registration fee for their participation in an upcoming APHCON/BTG conference. Members who have paid their membership fee for the current year will also receive a discount on subscription to medical journals published by APHCON.
b) Honorary Members
Honorary members have earned sufficient recognition for their work in medical research and/or promotion of the hematology and related fields. These members are nominated by the entire APHCON Board of Directors, or by a single member of the APHCON said board. Honorary members have all privileges of active members. In recognition of their exceptional contributions to hematology, honorary members are not required to pay membership dues and registration fees for APHCON/BTG conferences. They have no voting rights. Honorary membership is personal and cannot be transferred or acquired through succession.
c) Emeritus Members
Any member of the Consortium at age sixty-five years or professional retirement may request transfer to the status of Emeritus membership by written application to the Membership Committee. Conferral of the Emeritus classification will be awarded by a majority vote of the APHCON Board of Director. Emeritus members will have all privileges of active members but cannot vote and hold elective office in the Consortium. Emeritus members will pay dues and registration fees at a preferential rate.
d) Institutional members:
Accredited universities and colleges in APAC region are eligible for Institutional Membership. Membership is available to institutions with or without medical school programs, resident and fellowship training programs; and affiliated hospitals with varying membership benefits and dues.
e) Corporate members
APHCON offers the corporate community unique access to the issues and leaders shaping the APAC hematology oncology. The membership benefits and dues will be described accordingly
2. Suspension and/or Removal of Members
Members may be removed from the Consortium for actions unbecoming of a member, actions deleterious to the objectives of APHCON and/or continuous non-payment of dues to the Consortium. Reasons for removal must be presented in writing to the APHCON Board of Directors. The Board will appoint an Investigative Committee to study the nature of the complaint. Members will be given the opportunity for self-defense in writing to the Board. Removal from the Consortium must be approved by the majority of the Board.
3. Resignation
Resignation requests must be submitted in writing to the APHCON Board of Directors and are not considered effective until they are reviewed by the Board.
Article V
Finances
1. annual Membership Dues are payable to the APHCON and are payable in advance.
2. members are considered to be in continuous non-payment after they are in arrears
3. for two years and will be notified by the Membership Committee by means of a
4. “return receipt” registered letters. Members who are in arrears for three years will
5. have their membership revoked immediately for non-payment of dues.
6. 3 Registration fees are charged to members at APHCON/BTG conferences. Members who
7. have paid their membership dues in advance will receive discounted registration fees. Amounts and methods of payment of registration fees are determined by the Congress Committee.
8. subscription fees to APHCON publications are available at discounted rates to APHCON members who have paid their membership dues in advance. Subscription fees and methods of payment are determined by the Publishing Committee.
Article VI
APHCON Board of Directors
The APHCON Board consists of eleven (11) persons and is a balanced reflection of the professional world of hematologic science. The directors are appointed from the Consortium’s memberships and demonstrate an exemplary commitment to furthering the scientific research in the field of hematology and promoting an international platform of medical education and discussion. At predetermined intervals, or at the retirement of a Director, a Nomination Committee will be appointed to accept nominations for the vacant seat. Nominees must have a record of accomplishment in the field of medicine and hematology and display innovation and commitment to the APHCON objective of developing internationally cohesive standards of care and medical protocols in hematology.
The APHCON Board of Directors is in charge of managing the Consortium. The APHCON Board appoints from its members a chairman, with the title of “Executive Director,” co-chairman, secretary, and treasurer, who jointly constitute the Executive Board. The Secretary is responsible of the membership records of the Consortium and will ensure that minutes are taken of all meetings of the APHCON Board and that all persons concerned are invited to the meetings. The Secretary leads the Membership Committee. The treasurer is responsible for accounts and financial matters of the APHCON and leads the Business Affairs Committee.
APHCON President will be elected every 3-5 years. APHCON President will also serve as the Chair of APHCON Board for his term duration
Article VII
Special Committees
1. Congress Committee
The APHCON Board of Directors will appoint a Congress Committee deemed appropriate for the organization of a specific scientific program, commercial exhibition, social arrangements, and other congress activities. Membership in the Congress Committee and its sub-committees is at the discretion of the Executive Director. The Executive Director and APHCON Board may elect to appoint National Councilors from conference host countries on each Congress Committee.
The Congress Committee shall transact all business connected with the preparation, organization and conduct of the Congresses of the APHCON. Transactions always shall be governed by the Statutes and By-laws of the Consortium. It shall audit the accounts of the Treasurer of the Congress at the end of the Congress. The President or (if different) the Chairmen of the Congress Committee shall on his behalf prepare a report to be presented at the meeting of the Council at the time of the Congress to complete the business of the Congress and to certify the accounts of the Treasurer of the Congress.
2. Awards Committee
A committee for awards consisting of the APHCON Board of Directors and relevant committees will allocate awards that are made at a conference in the name of the Consortium. Awards may be conferred at the APHCON/BTG conferences and announced in APHCON print materials, including APHCON medical journals.
3. Membership Committee
The Membership Committee is led by the Secretary of the APHCON Board of Directors.
4. Publishing Committee
The Publishing Committee determines the content and schedule of APHCON medical journals in concert with its publishing partner. The Publishing Committee will work in concert with the Technology and Scientific Committees to promote the international dissemination of information in the field of hematology. The Committee will select material from APHCON/BTG conferences to be published in the APHCON medical journals.
5. Business Affairs Committee
The Business Affairs Committee is led by the Treasurer of the APHCON Board of Directors and will oversee the Consortium’s financial matters. The Business Affairs Committee will work in concert with the Technology and Scientific Educational Committees to promote APHCON.
6. Nomination Committee
The Nomination Committee is a special committee of five (5) members appointed by the Executive Director and the APHCON Board of Directors to fill vacancies on the APHCON Board.
7. Technology Committee
The Technology Committee is under the direction of the APHCON Executive Director and will explore the use of technology in emerging markets to promote exchange of information in the discipline of hematology. The committee will investigate and implement the use of technology in APHCON/BTG events and conferences to further educational objectives.
8. Scientific Education Committee
The Scientific Education Committee is under the direction of the APHCON Executive Director and will explore methods to promote greater awareness and standardization of medical protocol on an international level. The Committee will cultivate discourse by developing APHCON International Fellowships and invite accomplished physicians and scientists to leading academic medical centers.
Article VIII
Business Affairs
1. The APHCON Treasurer will receive and be the custodians of the funds of the Consortium. At each regular meeting for the Consortium, the Executive Director will propose a budget for the Consortium and for Congresses and APHCON/BTG Conferences for approval.
2. The Secretary and Treasurer of the Congress shall be responsible for the transaction of business in preparation for and conduct of the Congress.
The APHCON Treasurer shall receive and be the custodian of the registration fees and of such other funds as will be collected for the conduct of the Congress. In order facilitate organization of the appropriate local committees, the Treasurer may be advanced, upon request and approval by the Executive Director, an amount of money to be agreed in advance by the APHCON, such funds to be repaid after the Congress, out of fees and income.
3. Within 180 days following the close of the meeting the Treasurer shall submit the audited financial accounts in income and expenditure to the Executive Director.
4. Within 180 days following the close of the meeting the Secretary shall present his report for Congress was held. The report will be submitted to APHCON Board of Directors at their next regular meeting. The terms of office of the Secretary and of the Treasurer will be considered at an end after they have completed all the business connected with the preceding scientific meeting, and the report has been approved by the Council.
5) The Executive and Administrative body of the Consortium during the interval between Congresses shall consist of the Chairman of Council, President, and the three Secretaries-General. The Secretary-General of the Division from which the Chairman has been appointed shall be named as Executive Secretary. The Executive Director shall be empowered to enter into contracts and authorize such expenditure as may be necessary to carry on the affairs and the business of the Consortium. The Executive Director will supervise the affairs of the Consortium and delegate to the Congress committees any authority necessary for the organization and management of a Congress. Its actions shall always be covered by the Statutes and By-laws of the Consortium.
Article IX
General
Standing Rules for Consortium and Divisional Meetings
1. At all business meetings the Executive Director shall first call the members assembled to order for the purpose of transaction such business and appointing such committees as are required.
2. Non-members and members of the Consortium in arrears for subscription fees may participate in the Congress scientific session but will not be eligible for registration at the reduced rate that is charged to Members in good standing; they will be subject to all the rules and regulations relating to the Consortium.
3. Order of Business for APHCON congresses and other business sessions:
a. Call to order
b. The minutes of the previous meeting
c. Referred unfinished business
d. Report of Committees
e. Election of Members
f. New Business
g. Nominations
h. Any other business
_______________________________________________
Article 1
Name
The name of this organization is the Asia Pacific Hematology Consortium. The Consortium is a scientific association.
Article II
Objectives
The objectives of the Consortium shall be:
(a) to promote scientific research and medical science in the field of hematology
(b) to nurture educational discourse and cultivate the dissemination of knowledge and ideas relating to hematology-oncology
(c) to promote the continuing education in the investigation of hematology-oncology and related topics by encouraging international discussion and developing a cohesive standardization of hematological methods and standards of care
(d) to advance developments in hematology-oncology by developing and implementing clinical research programs.
As part of its functions, the Consortium will organize, at pre-determined intervals, scientific meetings to be held at least annually and will be called “Bridging the Gap Series: International Conference on Hematologic Malignancies.” The Board of Directors will determine the locations of the scientific meetings. Additionally, the Consortium will publish a scientific journal in concert with a publishing partner.
Article III
Duration
The Consortium is formed for an indefinite period and may be dissolved at any time with unanimous approval by the Board of Directors. The financial year of the Consortium coincides with the calendar year.
Article IV
Membership
1. Definition of Members: The membership of the Consortium consists of the following:
(a) Active Members (Members)
(b) Honorary Members
(c) Emeritus Members
(d) Institutional Members
(e) Corporate Members
a) Active Members
Active members are medical professionals or scientists of good professional standing and demonstrate continuing commitment to the field of hematology. The Membership Committee determines membership eligibility. Interested parties must submit an application to the Consortium. Applicants are informed of their admission via writing.
Application for Membership shall be made on the form authorized by the Consortium, signed by the applicant, recommended by two APHCON and approved by the Membership Committee. The application should include a list of qualifications, professional positions, and scientific contributions of the candidate. Applications are reviewed by the Membership Committee at its next regular meeting.
Active Members are required to pay an annual membership fee, which is set by the APHCON Board. Members under the age of 40 or members who have Emeritus classification receive preferential rates of membership. Members who have paid their membership fee for the current calendar year receive a discount on the registration fee for their participation in an upcoming APHCON/BTG conference. Members who have paid their membership fee for the current year will also receive a discount on subscription to medical journals published by APHCON.
b) Honorary Members
Honorary members have earned sufficient recognition for their work in medical research and/or promotion of the hematology and related fields. These members are nominated by the entire APHCON Board of Directors, or by a single member of the APHCON said board. Honorary members have all privileges of active members. In recognition of their exceptional contributions to hematology, honorary members are not required to pay membership dues and registration fees for APHCON/BTG conferences. They have no voting rights. Honorary membership is personal and cannot be transferred or acquired through succession.
c) Emeritus Members
Any member of the Consortium at age sixty-five years or professional retirement may request transfer to the status of Emeritus membership by written application to the Membership Committee. Conferral of the Emeritus classification will be awarded by a majority vote of the APHCON Board of Director. Emeritus members will have all privileges of active members but cannot vote and hold elective office in the Consortium. Emeritus members will pay dues and registration fees at a preferential rate.
d) Institutional members:
Accredited universities and colleges in APAC region are eligible for Institutional Membership. Membership is available to institutions with or without medical school programs, resident and fellowship training programs; and affiliated hospitals with varying membership benefits and dues.
e) Corporate members
APHCON offers the corporate community unique access to the issues and leaders shaping the APAC hematology oncology. The membership benefits and dues will be described accordingly
2. Suspension and/or Removal of Members
Members may be removed from the Consortium for actions unbecoming of a member, actions deleterious to the objectives of APHCON and/or continuous non-payment of dues to the Consortium. Reasons for removal must be presented in writing to the APHCON Board of Directors. The Board will appoint an Investigative Committee to study the nature of the complaint. Members will be given the opportunity for self-defense in writing to the Board. Removal from the Consortium must be approved by the majority of the Board.
3. Resignation
Resignation requests must be submitted in writing to the APHCON Board of Directors and are not considered effective until they are reviewed by the Board.
Article V
Finances
1. annual Membership Dues are payable to the APHCON and are payable in advance.
2. members are considered to be in continuous non-payment after they are in arrears
3. for two years and will be notified by the Membership Committee by means of a
4. “return receipt” registered letters. Members who are in arrears for three years will
5. have their membership revoked immediately for non-payment of dues.
6. 3 Registration fees are charged to members at APHCON/BTG conferences. Members who
7. have paid their membership dues in advance will receive discounted registration fees. Amounts and methods of payment of registration fees are determined by the Congress Committee.
8. subscription fees to APHCON publications are available at discounted rates to APHCON members who have paid their membership dues in advance. Subscription fees and methods of payment are determined by the Publishing Committee.
Article VI
APHCON Board of Directors
The APHCON Board consists of eleven (11) persons and is a balanced reflection of the professional world of hematologic science. The directors are appointed from the Consortium’s memberships and demonstrate an exemplary commitment to furthering the scientific research in the field of hematology and promoting an international platform of medical education and discussion. At predetermined intervals, or at the retirement of a Director, a Nomination Committee will be appointed to accept nominations for the vacant seat. Nominees must have a record of accomplishment in the field of medicine and hematology and display innovation and commitment to the APHCON objective of developing internationally cohesive standards of care and medical protocols in hematology.
The APHCON Board of Directors is in charge of managing the Consortium. The APHCON Board appoints from its members a chairman, with the title of “Executive Director,” co-chairman, secretary, and treasurer, who jointly constitute the Executive Board. The Secretary is responsible of the membership records of the Consortium and will ensure that minutes are taken of all meetings of the APHCON Board and that all persons concerned are invited to the meetings. The Secretary leads the Membership Committee. The treasurer is responsible for accounts and financial matters of the APHCON and leads the Business Affairs Committee.
APHCON President will be elected every 3-5 years. APHCON President will also serve as the Chair of APHCON Board for his term duration
Article VII
Special Committees
1. Congress Committee
The APHCON Board of Directors will appoint a Congress Committee deemed appropriate for the organization of a specific scientific program, commercial exhibition, social arrangements, and other congress activities. Membership in the Congress Committee and its sub-committees is at the discretion of the Executive Director. The Executive Director and APHCON Board may elect to appoint National Councilors from conference host countries on each Congress Committee.
The Congress Committee shall transact all business connected with the preparation, organization and conduct of the Congresses of the APHCON. Transactions always shall be governed by the Statutes and By-laws of the Consortium. It shall audit the accounts of the Treasurer of the Congress at the end of the Congress. The President or (if different) the Chairmen of the Congress Committee shall on his behalf prepare a report to be presented at the meeting of the Council at the time of the Congress to complete the business of the Congress and to certify the accounts of the Treasurer of the Congress.
2. Awards Committee
A committee for awards consisting of the APHCON Board of Directors and relevant committees will allocate awards that are made at a conference in the name of the Consortium. Awards may be conferred at the APHCON/BTG conferences and announced in APHCON print materials, including APHCON medical journals.
3. Membership Committee
The Membership Committee is led by the Secretary of the APHCON Board of Directors.
4. Publishing Committee
The Publishing Committee determines the content and schedule of APHCON medical journals in concert with its publishing partner. The Publishing Committee will work in concert with the Technology and Scientific Committees to promote the international dissemination of information in the field of hematology. The Committee will select material from APHCON/BTG conferences to be published in the APHCON medical journals.
5. Business Affairs Committee
The Business Affairs Committee is led by the Treasurer of the APHCON Board of Directors and will oversee the Consortium’s financial matters. The Business Affairs Committee will work in concert with the Technology and Scientific Educational Committees to promote APHCON.
6. Nomination Committee
The Nomination Committee is a special committee of five (5) members appointed by the Executive Director and the APHCON Board of Directors to fill vacancies on the APHCON Board.
7. Technology Committee
The Technology Committee is under the direction of the APHCON Executive Director and will explore the use of technology in emerging markets to promote exchange of information in the discipline of hematology. The committee will investigate and implement the use of technology in APHCON/BTG events and conferences to further educational objectives.
8. Scientific Education Committee
The Scientific Education Committee is under the direction of the APHCON Executive Director and will explore methods to promote greater awareness and standardization of medical protocol on an international level. The Committee will cultivate discourse by developing APHCON International Fellowships and invite accomplished physicians and scientists to leading academic medical centers.
Article VIII
Business Affairs
1. The APHCON Treasurer will receive and be the custodians of the funds of the Consortium. At each regular meeting for the Consortium, the Executive Director will propose a budget for the Consortium and for Congresses and APHCON/BTG Conferences for approval.
2. The Secretary and Treasurer of the Congress shall be responsible for the transaction of business in preparation for and conduct of the Congress.
The APHCON Treasurer shall receive and be the custodian of the registration fees and of such other funds as will be collected for the conduct of the Congress. In order facilitate organization of the appropriate local committees, the Treasurer may be advanced, upon request and approval by the Executive Director, an amount of money to be agreed in advance by the APHCON, such funds to be repaid after the Congress, out of fees and income.
3. Within 180 days following the close of the meeting the Treasurer shall submit the audited financial accounts in income and expenditure to the Executive Director.
4. Within 180 days following the close of the meeting the Secretary shall present his report for Congress was held. The report will be submitted to APHCON Board of Directors at their next regular meeting. The terms of office of the Secretary and of the Treasurer will be considered at an end after they have completed all the business connected with the preceding scientific meeting, and the report has been approved by the Council.
5) The Executive and Administrative body of the Consortium during the interval between Congresses shall consist of the Chairman of Council, President, and the three Secretaries-General. The Secretary-General of the Division from which the Chairman has been appointed shall be named as Executive Secretary. The Executive Director shall be empowered to enter into contracts and authorize such expenditure as may be necessary to carry on the affairs and the business of the Consortium. The Executive Director will supervise the affairs of the Consortium and delegate to the Congress committees any authority necessary for the organization and management of a Congress. Its actions shall always be covered by the Statutes and By-laws of the Consortium.
Article IX
General
Standing Rules for Consortium and Divisional Meetings
1. At all business meetings the Executive Director shall first call the members assembled to order for the purpose of transaction such business and appointing such committees as are required.
2. Non-members and members of the Consortium in arrears for subscription fees may participate in the Congress scientific session but will not be eligible for registration at the reduced rate that is charged to Members in good standing; they will be subject to all the rules and regulations relating to the Consortium.
3. Order of Business for APHCON congresses and other business sessions:
a. Call to order
b. The minutes of the previous meeting
c. Referred unfinished business
d. Report of Committees
e. Election of Members
f. New Business
g. Nominations
h. Any other business